Mirabegron (YM178) OCAS
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mirabegron (YM178) OCAS, covering 2013-07-02 to 2013-07-02. Get the full timeline:
Most recent: Clinical Trial Update: To Evaluate the Blood and Urine Concentration and the Safety and Tolerability of Increasing Repeated Doses of Mirabegron (YM178) OCAS in Healthy Young and Elderly Males and Healthy Young and Elderly Females [Phase 1]